ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Recombinant Protein C Cuts Risk Of Sepsis Death

February 22, 2002

Frederick Center Should Have Top Scientist As Director, 20% Of Budget or Basic Research

December 21, 1973

Tamoxifen Listed By IARC Report As Carcinogen CTRF Seeks Applicants

March 1, 1996

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

September 29, 2006

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002

Dole Visits Roswell Park, Hails PSA Test

January 28, 1994